75
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis

, , ORCID Icon, , , ORCID Icon, , & show all
Pages 10043-10050 | Published online: 29 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Martin Lund, Torben B Pedersen, Søren Feddersen, Louise D Østergaard, Charlotte A Poulsen, Christian Enggaard, Mads H A Poulsen & Lars Lund. (2022) Plasma Chemokine C-C Motif Ligand 2 as a Potential Biomarker for Prostate Cancer. Research and Reports in Urology 14, pages 33-38.
Read now

Articles from other publishers (6)

Stefan E. Eng, Benjamin Basasie, Alfonso Lam, O. John Semmes, Dean A. Troyer, Geoffrey D. Clarke, Abhijit G. Sunnapwar, Robin J. Leach, Teresa L. Johnson-Pais, Lori J. Sokoll, Daniel W. Chan, Jeffrey J. Tosoian, Javed Siddiqui, Arul M. Chinnaiyan, Ian M. ThompsonJr.Jr., Paul C. Boutros & Michael A. Liss. (2022) Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy. Prostate Cancer and Prostatic Diseases 27:1, pages 65-72.
Crossref
Mario Israel Oregel-Cortez, Héctor Frayde-Gómez, Georgina Quintana-González, Victor García-González, Jose Gustavo Vazquez-Jimenez & Octavio Galindo-Hernández. (2023) Resistin Induces Migration and Invasion in PC3 Prostate Cancer Cells: Role of Extracellular Vesicles. Life 13:12, pages 2321.
Crossref
Seyfettin Üstünsoy. 2023. Biomarkers in Diabetes. Biomarkers in Diabetes 67 82 .
Reshu Tewari, Deepika Dalal, Shikha Rawat, Ashish Malik, Veena Ghalaut & Anurag Bajpai. (2022) The altered levels of adiponectin - leptin as predictive biomarkers to estimate the severity of prostate cancer. Biomedicine 42:5, pages 920-924.
Crossref
Seyfettin Üstünsoy. 2022. Biomarkers in Diabetes. Biomarkers in Diabetes 1 16 .
Xiaohui Sun, Ding Ye, Lingbin Du, Yu Qian, Xia Jiang & Yingying Mao. (2020) Genetically predicted levels of circulating cytokines and prostate cancer risk: A Mendelian randomization study. International Journal of Cancer 147:9, pages 2469-2478.
Crossref